The pathway ‘HULC/ubiquitin-specific peptidase 22 (USP22)/Sirt1/protective autophagy’ increases HCC cells sensitivity to chemotherapeutic agents. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.